Exercise and Breathing Program Before and After Bariatric Surgery in Obese Adults
Tests an exercise and breathing program around bariatric surgery in adults with obesity.
Plain-language title generated from the registry record
Registry title: Impact of a Perioperative Physical Exercise and Respiratory Physiotherapy Program on the Patient Undergoing Bariatric Surgery
Key facts
- Where
- Vigo, SpainSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults who are on the waiting list for bariatric (weight-loss) surgery at one hospital in Vigo. It tests an exercise and breathing physiotherapy programme before and after surgery.
- Age
- Over 18 and under 69 years old.
- Sex
- All sexes can join.
- Disease stage
- Patients undergoing bariatric surgery at the General and Digestive Surgery Department of the Álvaro Cunqueiro Hospital in Vigo.
- Earlier treatment
- People treated for diabetes with GLP-1 agonists and/or SGLT2 inhibitors cannot join if the dose was not stable in the last 3 months.
Main reasons for not taking part
- Refusing to join the study
- Not able to understand taking part in a study
- Urgent surgery
- Combined surgery with another surgical service
- Cannot read and write, or depends on a legal representative
Read by machine on 9 November 2026.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 69 years old?
Source: NCT06987903, who can take part
Where in Spain
- Hospital Alvaro CunqueiroVigo, SpainTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Fundacin Biomedica Galicia Sur
- Trial code
- NCT06987903
- Record updated
- 13 October 2026
- Original description
The goal of this clinical trial is to see the impact of a physical exercise programme and respiratory physiotherapy before and after bariatric surgery in obese patients. The main questions it aims to answer are:Read full original descriptionShow less
Impact of a Perioperative Physical Exercise and Respiratory Physiotherapy Program on the Patient Undergoing Bariatric Surgery
The goal of this clinical trial is to see the impact of a physical exercise programme and respiratory physiotherapy before and after bariatric surgery in obese patients. The main questions it aims to answer are:
Could it help to avoid decompensation of underlying diseases? Could it reduce the risks associated with the intervention and the number of adverse effects during the postoperative period? Could it reduce the number of patients and encourage early discharge? How does exercise affect epigenetics in obese patients undergoing bariatric surgery? Can we correlate epigenectic markers obtained from tissue obtained by invasive procedures such as fat or muscle to those obtained by non-invasive methods such as blood and saliva samples? How does exercise affect the hepatic tissue in obese patients undergoing bariatric surgery? And are the any predictive markers in pre-exercise samples that can correlate with the evolution of liver diseases such asl NALFD or NASH?
Researchers will compare one group of subjects performing the exercise programme and respiratory physiotherapy and anoher group performing the normal activities of routine clinical practice.
Participants, who are on the surgical waiting list for bariatric surgery, will be assigned to one of the two groups. Participants in group 2 will follow the normal procedure before and after surgery. Participants in group 1 will be asked to do a exercise programme and respiratory physiotherapy before and after surgery.
Inclusion: Patients undergoing bariatric surgery at the General and Digestive Surgery Department of the Álvaro Cunqueiro Hospital in Vigo; Be over 18 and under 69 years old; Sign the informed consent to participate in the study.
Exclusion: Patients undergoing combined surgery with another surgical service; Patients on treatment for diabetes with GLP-1 agonists (glucagon-like peptide type 1 agonists) and/or SGLT2 inhibitors (sodium-glucose cotransporter type 2 inhibitors) whose dose is not stable in the last 3 months; Patient's refusal to enter the study; Inability to comprehend participation in a study; Urgent interventions; Patients who cannot read and write or are dependent on a legal representative.